24 results
Mass General Hospital COVID19 Critical Care Treatment Guide

#COVID19 #CriticalCare #Treatment #MGH #Management #Coronavirus #SARSCOV2
Critical Care Treatment ... Guide #COVID19 ... #CriticalCare # ... Treatment #MGH # ... Management #Coronavirus
COVID-19 review…here is a list of some of the drugs that are currently being used or
of some of the drugs ... most effective treatments ... here are the 4 drug ... #CoronaVirus #Treatment ... #Pharmacology #CriticalCare
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... #treatment #sarscov2 ... #criticalcare # ... coronavirus #medications ... #alternatives #Drugs
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
COVID-19 Diagnosis ... Summary • Clinical ... #COVID19 #diagnosis ... #management #treatment ... summary #sarscov2 #coronavirus
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Treatment of COVID ... highlighted circle= clinical ... #COVID19 #Pharmacology ... #Table #Management
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... emergency 2020-3-12 Diagnosis ... #Cheatsheet #Diagnosis ... #CriticalCare
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
-19 The diagnosis ... and treatment of ... Internet Book of Critical ... management #schema #criticalcare ... algorithm #SARSCOV2 #Coronavirus
Rhabdomyolysis - Differential Diagnosis and Management Summary

Trauma:
 • Immobilization, Crush iniury, Compartment syndrome, Electrical injury
Exertional:
 •
- Differential Diagnosis ... Drugs (Statins), ... Dermatomyositis) AKI - Pathophysiology ... per day until stable ... #Differential #Diagnosis
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... : No • Treatment ... Reactions #hematology #diagnosis ... #comparison #table
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... accumulation of clinical ... Assessment • Clinical ... immune deficiency, Drugs ... #management #treatment